AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Ado

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH S

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Mon

CapsoVision NASDAQ: CV reported steady first-quarter revenue and said it continues to advance artifi

CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript

CapsoVision (NASDAQ:CV) reported quarterly losses of $(0.15) per share which missed the analyst cons

SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stag

SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st

CapsoVision (NASDAQ: CV - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are bot

Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowe

CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript

CapsoVision (NASDAQ:CV) reported quarterly earnings of $0.02 per share which beat the analyst consen

CapsoVision, Inc. (the "Company") (NASDAQ: CV), a commercial-stage medical technology compan

Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results Reports Prelimina

SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-st

CapsoVision (NASDAQ: CV - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report)

CapsoVision, Inc. (NASDAQ: CV - Get Free Report) saw a large increase in short interest in the month

CapsoVision (NASDAQ: CV - Get Free Report) and Profusa (NASDAQ: PFSA - Get Free Report) are both sma

CNBC's Brian Sullivan reports on President Trump's commentary about Venezuela's oil industry during

Shares of CapsoVision, Inc. (NASDAQ: CV - Get Free Report) gapped down prior to trading on Friday. T

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and str

Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and rais

U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, C

U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, C

CapsoVision, Inc. (NASDAQ: CV - Get Free Report)'s share price traded down 6.5% on Friday. The stock

CapsoVision's (NASDAQ: CV - Get Free Report) lock-up period will expire on Monday, December 29th. Ca